BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11313707)

  • 1. Niemann-Pick Disease versus acid sphingomyelinase deficiency.
    Lozano J; Morales A; Cremesti A; Fuks Z; Tilly JL; Schuchman E; Gulbins E; Kolesnick R
    Cell Death Differ; 2001 Jan; 8(1):100-3. PubMed ID: 11313707
    [No Abstract]   [Full Text] [Related]  

  • 2. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease.
    Horinouchi K; Erlich S; Perl DP; Ferlinz K; Bisgaier CL; Sandhoff K; Desnick RJ; Stewart CL; Schuchman EH
    Nat Genet; 1995 Jul; 10(3):288-93. PubMed ID: 7670466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of acid sphingomyelinase in Niemann-Pick mice].
    Sakiyama T; Kitagawa T
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):484-90. PubMed ID: 2024027
    [No Abstract]   [Full Text] [Related]  

  • 4. [Niemann-Pick disease types A and B].
    Ohno K
    Nihon Rinsho; 1995 Dec; 53(12):3014-8. PubMed ID: 8577051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An animal model of human acid sphingomyelinase deficiency (Niemann-Pick disease) and the study of its enzyme replacement (the Japan Society of Human Genetics award lecture).
    Kitagawa T
    Jinrui Idengaku Zasshi; 1987 Jun; 32(2):55-69. PubMed ID: 2830422
    [No Abstract]   [Full Text] [Related]  

  • 6. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
    He X; Chen F; Gatt S; Schuchman EH
    Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sphingomyelinase activity in a patient with Niemann-Pick disease].
    Sengers RC; Wevers RA; van Haelst UJ; Smeets HL
    Tijdschr Kindergeneeskd; 1989 Apr; 57(2):70-3. PubMed ID: 2545015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann-Pick disease.
    Schuchman EH
    FEBS Lett; 2010 May; 584(9):1895-900. PubMed ID: 19944693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Niemann-Pick disease [type A and B] (acid sphingomyelinase deficiencies)].
    Higaki K; Ohno K
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):360-2. PubMed ID: 9645083
    [No Abstract]   [Full Text] [Related]  

  • 11. Biosynthesis of sphingomyelinase in normal and Niemann-Pick fibroblasts.
    Jobb EA; Callahan JW
    Biochem Cell Biol; 1989; 67(11-12):801-7. PubMed ID: 2559757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis of Niemann-Pick diseases types A, B and C.
    Vanier MT
    Prenat Diagn; 2002 Jul; 22(7):630-2. PubMed ID: 12124701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dimethylsulfoxide on sphingomyelinase in cultured human fibroblasts and correction of sphingomyelinase deficiency in fibroblasts from Niemann-Pick patients.
    Sakuragawa N; Sato M; Yoshida Y; Kamo I; Arima M; Satoyoshi E
    Biochem Biophys Res Commun; 1985 Jan; 126(2):756-62. PubMed ID: 2983689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A.
    Daloze P; Delvin EE; Glorieux FH; Corman JL; Bettez P; Toussi T
    Am J Med Genet; 1977; 1(2):229-39. PubMed ID: 345809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingomyelinase defect in Niemann-Pick disease, type C, fibroblasts.
    Besley GT
    FEBS Lett; 1977 Aug; 80(1):71-4. PubMed ID: 19295
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte enzymes in the detection of Niemann-Pick Carriers.
    Hardy B; Hoffman J; Neri A
    Biomed Pharmacother; 1982; 36(8-9):372-5. PubMed ID: 7182017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease.
    Barbon CM; Ziegler RJ; Li C; Armentano D; Cherry M; Desnick RJ; Schuchman EH; Cheng SH
    Mol Ther; 2005 Sep; 12(3):431-40. PubMed ID: 16099409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of caveolin-1 in heterozygous Niemann-Pick type II human fibroblasts.
    Garver WS; Hsu SC; Erickson RP; Greer WL; Byers DM; Heidenreich RA
    Biochem Biophys Res Commun; 1997 Jul; 236(1):189-93. PubMed ID: 9223450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niemann-Pick type C disease: novel NPC1 mutations and characterization of the concomitant acid sphingomyelinase deficiency.
    Tamura H; Takahashi T; Ban N; Torisu H; Ninomiya H; Takada G; Inagaki N
    Mol Genet Metab; 2006 Feb; 87(2):113-21. PubMed ID: 16143556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Type A and B Niemann-Pick disease].
    Higaki K; Ohno K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():305-8. PubMed ID: 11347081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.